FEops HEARTguideTM vs ZEUS System (Zio Watch)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by FEops
VS
by iRhythm Technologies, Inc.

AI Verdict

Tool A, FEops HEARTguideTM, is designed for pre-procedural planning of structural heart interventions, utilizing AI and digital twins to optimize device sizing and positioning. In contrast, Tool B, the ZEUS System (Zio Watch), is an AI-powered wearable for long-term continuous cardiac monitoring, focused on detecting and characterizing arrhythmias. While both leverage AI in cardiology, their distinct applications make them suitable for different stages of patient care: interventional planning versus diagnostic monitoring.

Choose FEops HEARTguideTM if…

Choose FEops HEARTguideTM if you require advanced pre-procedural planning for complex structural heart interventions such as TAVI or LAAO. This platform is ideal for optimizing device sizing and positioning through predictive simulations and detailed anatomical insights derived from AI-based analysis of CT scans.

View FEops HEARTguideTM →

Choose ZEUS System (Zio Watch) if…

Choose ZEUS System (Zio Watch) if you need long-term, continuous cardiac monitoring to detect and characterize intermittent arrhythmias, particularly Atrial Fibrillation. This wearable solution provides up to 14 days of ECG and PPG data collection, leveraging AI to deliver actionable insights for diagnosing and managing cardiac rhythm disorders.

View ZEUS System (Zio Watch) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature FEops HEARTguideTM ZEUS System (Zio Watch)
Pricing Unknown Contact vendor
Deployment Cloud-based Cloud-based system with a wearable device
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

ZEUS System (Zio Watch)

Tool B (ZEUS System) offers a patient-centric design with a comfortable, smaller, and lighter wearable device, complemented by dedicated patient and provider mobile apps for ease of use and engagement. While Tool A (FEops HEARTguideTM) provides a cloud-based platform with interactive 2D/3D viewers and DICOM integration for specialists, Tool B's broader focus on user experience for both patients and clinicians, aiming for high patient compliance, gives it an advantage in overall usability.

Clinical Value

FEops HEARTguideTM

Tool A (FEops HEARTguideTM) provides higher, more direct clinical value by offering predictive simulations and anatomical insights to optimize device sizing and positioning for complex structural heart procedures like TAVI and LAAO. Clinical trials have demonstrated significantly improved procedural efficiency, reduced complications, and better patient outcomes. Tool B offers strong diagnostic value for arrhythmia detection, but Tool A's impact on optimizing high-stakes interventions is more profound.

Pricing & Value

ZEUS System (Zio Watch)

While both tools have opaque pricing, Tool B (ZEUS System) provides more transparency regarding its reimbursement model, indicating coverage by major commercial insurers and Medicare, with a proposed national Medicare rate. It also offers patient payment programs and financial assistance, suggesting a more structured approach to affordability and value for a broader patient base. Tool A's service-based model, where FEops prepares the analysis, might lead to less predictable per-case costs.

Enterprise Readiness

Tie

Both tools demonstrate strong enterprise readiness, being FDA cleared, HIPAA compliant, and offering BAAs, with cloud-based deployments. Tool A (FEops HEARTguideTM) features a DICOM interface and partnerships for integration into clinical workflows. Tool B (ZEUS System) offers a comprehensive ecosystem with a provider portal, mobile app, and explicit EHR integration, indicating robust readiness for broader healthcare system adoption.

Innovation

FEops HEARTguideTM

Tool A (FEops HEARTguideTM) demonstrates greater innovation by utilizing a 'digital twin platform' and 'predictive simulations' to model the interaction between devices and patient anatomy for pre-procedural planning. This goes beyond standard AI-driven image analysis to offer a more advanced and disruptive approach to personalized medicine and procedural optimization. Tool B's AI-powered wearable for long-term monitoring is also innovative but less fundamentally disruptive than the digital twin concept for procedural planning.

Support & Docs

ZEUS System (Zio Watch)

Tool B (ZEUS System) clearly outlines multiple channels for support and documentation for both patients and healthcare professionals, including dedicated apps with educational content, FAQs, online user manuals, and direct customer care via phone. Tool A mentions training materials on its platform but lacks the explicit, multi-faceted support structure evident for Tool B.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature FEops HEARTguideTM ZEUS System (Zio Watch)
Name FEops HEARTguideTM ZEUS System (Zio Watch)
Primary Use Case Structural heart procedure planning, optimizing device sizing and positioning for interventions like TAVI and LAAO. Long-term continuous cardiac monitoring to detect and characterize Atrial Fibrillation (AFib) and other cardiac arrhythmias.
Key Technology / Core Functionality AI and digital twin platform, predictive simulation technology, AI-based anatomical measurements from CT scans. Wearable biosensor (Zio Watch) for continuous ECG and PPG data, AI-powered algorithm for arrhythmia detection and analysis.
Target Conditions / Procedures TAVI, LAAO (structural heart interventions) Atrial Fibrillation (AFib) and other cardiac arrhythmias
User Interface / Access Cloud-based platform, DICOM interface, interactive 2D and 3D viewer. ZioSuiteu00ae portal, provider mobile app, MyZiou00ae patient app.

Videos

Demos, reviews, and walkthroughs featuring FEops HEARTguideTM and ZEUS System (Zio Watch).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

FEops HEARTguideTM is designed for structural heart procedure planning, specifically providing predictive simulations and anatomical insights to optimize device sizing and positioning for interventions like TAVI and LAAO. In contrast, the ZEUS System (Zio Watch) is an AI-powered wearable for long-term continuous cardiac monitoring, focused on detecting and characterizing Atrial Fibrillation (AFib) and other cardiac arrhythmias.
FEops HEARTguideTM utilizes input data, such as CT scans, provided by clinicians to perform AI-based anatomical measurements and predictive simulations. The ZEUS System (Zio Watch) acquires data through a wearable biosensor (Zio Watch) that continuously collects ECG and PPG data from the patient.
FEops HEARTguideTM offers predictive simulations of device-anatomy interaction, AI-based anatomical measurements from CT scans, and an interactive 2D and 3D viewer for detailed analysis to optimize device placement. The ZEUS System (Zio Watch) provides advanced arrhythmia detection and analysis, including characterization of AFib burden, in clinically actionable reports with high physician agreement.
FEops HEARTguideTM is primarily intended for Cardiology, Cardiothoracic Surgery, and Radiology, given its focus on structural heart procedure planning. The ZEUS System (Zio Watch) is designed for use in Cardiology, Family Medicine, and Internal Medicine, catering to a broader range of physicians involved in cardiac rhythm management.
FEops HEARTguideTM focuses on pre-procedural planning, providing a one-time analysis based on the provided CT scan data for structural heart interventions. In contrast, the ZEUS System (Zio Watch) offers long-term continuous monitoring for up to 14 days to detect and characterize cardiac arrhythmias.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.